Nicolet Bankshares’s Alexion Pharmaceuticals ALXN Stock Holding History

Nicolet Bankshares’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,104	Closed	-$475K	–	210
2021 Q1	$475K	Hold	3,104	–	–	0.13%	128
2020 Q4	$485K	Hold	3,104	–	–	0.15%	118
2020 Q3	$355K	Hold	3,104	–	–	0.12%	134
2020 Q2	$348K	Hold	3,104	–	–	0.13%	125
2020 Q1	$279K	Hold	3,104	–	–	0.13%	131
2019 Q4	$336K	Hold	3,104	–	–	0.12%	143
2019 Q3	$304K	Hold	3,104	–	–	0.12%	142
2019 Q2	$407K	Hold	3,104	–	–	0.17%	114
2019 Q1	$420K	Sell	3,104 -311	-9%	-$38.7K	0.17%	113
2018 Q4	$332K	Hold	3,415	–	–	0.16%	121
2018 Q3	$475K	Hold	3,415	–	–	0.19%	102
2018 Q2	$424K	Sell	3,415 -128	-4%	-$15K	0.18%	110
2018 Q1	$395K	Hold	3,543	–	–	0.17%	120
2017 Q4	$424K	Buy	3,543 +692	+24%	+$84.3K	0.18%	114
2017 Q3	$400K	Hold	2,851	–	–	0.18%	112
2017 Q2	$347K	Buy	+2,851	New	+$332K	0.16%	124

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Nicolet Bankshares's ALXN Position: Q2 2021 in Review

Nicolet Bankshares sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 3,104 shares — an estimated $475K sold.

Nicolet Bankshares first reported a position in ALXN in Q2 2017 and held it in 16 quarters. The position peaked at $485K in Q4 2020. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

Nicolet Bankshares reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Nicolet Bankshares sold 3,104 Alexion Pharmaceuticals shares in Q2 2021, an estimated $475K.
Nicolet Bankshares first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 16 quarters.
Nicolet Bankshares's Alexion Pharmaceuticals position peaked at $485K in Q4 2020.
707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Nicolet Bankshares's 13F filing for Q2 2021, filed 11 Aug 2021.